Literature DB >> 29502310

Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma.

Sheng-Chieh Chan1, Chih-Hua Yeh2, Tzu-Chen Yen1, Shu-Hang Ng3, Joseph Tung-Chieh Chang4, Chien-Yu Lin4, Tsang Yen-Ming4, Kang-Hsing Fan4, Bing-Shen Huang4, Cheng-Lung Hsu5, Kai-Ping Chang6, Hung-Ming Wang5, Chun-Ta Liao6.   

Abstract

PURPOSE: Both head and neck magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) play a crucial role in the staging of primary nasopharyngeal carcinoma (NPC). In this study, we sought to prospectively investigate the clinical utility of simultaneous whole-body 18F-FDG PET/MRI for primary staging of NPC patients.
METHODS: We examined 113 patients with histologically confirmed NPC who underwent pretreatment, simultaneous whole-body PET/MRI and PET/CT for primary tumor staging. The images obtained with the different imaging modalities were interpreted independently and compared with each other.
RESULTS: PET/MRI increased the accuracy of head and neck MRI for assessment of primary tumor extent in four patients via addition of FDG uptake information to increase the conspicuity of morphologically subtle lesions. PET/MR images were more discernible than PET/CT images for mapping tumor extension, especially intracranial invasion. Regarding the N staging assessment, the sensitivity of PET/MRI (99.5%) was higher than that of head and neck MRI (94.2%) and PET/CT (90.9%). PET/MRI was particularly useful for distinguishing retropharyngeal nodal metastasis from adjacent nasopharyngeal tumors. For distant metastasis evaluation, PET/MRI exhibited a similar sensitivity (90% vs. 86.7% vs. 83.3%), but higher positive predictive value (93.1% vs. 78.8% vs. 83.3%) than whole-body MRI and PET/CT, respectively.
CONCLUSIONS: For tumor staging of NPC, simultaneous whole-body PET/MRI was more accurate than head and neck MRI and PET/CT, and may serve as a single-step staging modality.

Entities:  

Keywords:  Head and neck cancer; MRI; Nasopharyngeal carcinoma; PET; Simultaneous PET/MRI; Tumor staging

Mesh:

Substances:

Year:  2018        PMID: 29502310     DOI: 10.1007/s00259-018-3986-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  39 in total

1.  [Comparison between PET/CT and MRI in diagnosing lymph node metastasis and N staging of nasopharyngeal carcinoma].

Authors:  Gu-yi Zhang; Wei-han Hu; Li-zhi Liu; Hu-bing Wu; Yuan-hong Gao; Li Li; Yi Pan; Quan-shi Wang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2006-05

2.  Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer.

Authors:  Carlo Cavaliere; Valeria Romeo; Marco Aiello; Massimo Mesolella; Brigida Iorio; Luigi Barbuto; Elena Cantone; Emanuele Nicolai; Mario Covello
Journal:  Eur J Radiol       Date:  2016-12-31       Impact factor: 3.528

3.  Differentiation between small hepatic hemangiomas and metastases on MR images: importance of size-specific quantitative criteria.

Authors:  K Itoh; S Saini; P F Hahn; N Imam; J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1990-07       Impact factor: 3.959

4.  Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

Authors:  Gaspar Delso; Sebastian Fürst; Björn Jakoby; Ralf Ladebeck; Carl Ganter; Stephan G Nekolla; Markus Schwaiger; Sibylle I Ziegler
Journal:  J Nucl Med       Date:  2011-11-11       Impact factor: 10.057

5.  Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.

Authors:  Joseph Tung-Chieh Chang; Sheng-Chieh Chan; Tzu-Chen Yen; Chun-Ta Liao; Chien-Yu Lin; Kun-Ju Lin; I-How Chen; Hung-Ming Wang; Yu-Chen Chang; Tsung-Ming Chen; Chung-Jan Kang; Shu-Hang Ng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

6.  The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.

Authors:  Tzu-Chen Yen; Joseph Tung-Chieh Chang; Shu-Hang Ng; Yu-Chen Chang; Sheng-Chieh Chan; Kun-Ju Lin; Wuu-Jyh Lin; Ying-Kai Fu; Chen-Yu Lin
Journal:  J Nucl Med       Date:  2005-03       Impact factor: 10.057

7.  Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.

Authors:  Paul Stolzmann; Patrick Veit-Haibach; Natalie Chuck; Cristina Rossi; Thomas Frauenfelder; Hatem Alkadhi; Gustav von Schulthess; Andreas Boss
Journal:  Invest Radiol       Date:  2013-05       Impact factor: 6.016

8.  Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Chun-Ta Liao; Sheung-Fat Ko; Hung-Ming Wang; Yau-Yau Wai; Jiun-Jie Wang; Min-Chi Chen
Journal:  Eur Radiol       Date:  2009-12       Impact factor: 5.315

9.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

10.  PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner.

Authors:  Franz Wolfgang Hirsch; Bernhard Sattler; Ina Sorge; Lars Kurch; Adrian Viehweger; Lutz Ritter; Peter Werner; Thies Jochimsen; Henryk Barthel; Uta Bierbach; Holger Till; Osama Sabri; Regine Kluge
Journal:  Pediatr Radiol       Date:  2013-01-11
View more
  21 in total

1.  Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.

Authors:  Chih-Hua Yeh; Sheng-Chieh Chan; Chien-Yu Lin; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Kang-Hsing Fan; Hung-Ming Wang; Chun-Ta Liao; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

2.  A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study.

Authors:  Chunxia Qin; Fang Liu; Jing Huang; Weiwei Ruan; Qingyao Liu; Yongkang Gai; Fan Hu; Dawei Jiang; Yu Hu; Kunyu Yang; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-20       Impact factor: 9.236

3.  Hybrid PET/MRI in major cancers: a scoping review.

Authors:  Anni Morsing; Malene Grubbe Hildebrandt; Mie Holm Vilstrup; Sara Elisabeth Wallenius; Oke Gerke; Henrik Petersen; Allan Johansen; Thomas Lund Andersen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-02       Impact factor: 9.236

4.  Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.

Authors:  Yongfeng Piao; Caineng Cao; Yuanfan Xu; Shuang Huang; Feng Jiang; Ting Jin; Qifeng Jin; Yonghong Hua; Qiaoying Hu; Xiaozhong Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-29       Impact factor: 2.503

5.  Longitudinal evaluation of five nasopharyngeal carcinoma animal models on the microPET/MR platform.

Authors:  Jingjing Shi; Zhichao Xue; Kel Vin Tan; Hui Yuan; Anna Chi Man Tsang; Sai Wah Tsao; Pek-Lan Khong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-04       Impact factor: 9.236

6.  Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma.

Authors:  Gauthier Delaby; Bahar Ataeinia; Jennifer Wo; Onofrio Antonio Catalano; Pedram Heidari
Journal:  Abdom Radiol (NY)       Date:  2021-03-27

Review 7.  Emerging radiotherapy technologies and trends in nasopharyngeal cancer.

Authors:  Michelle Tseng; Francis Ho; Yiat Horng Leong; Lea Choung Wong; Ivan Wk Tham; Timothy Cheo; Anne Wm Lee
Journal:  Cancer Commun (Lond)       Date:  2020-08-03

8.  Predictive value and changes of miR-34a after concurrent chemoradiotherapy and its association with cognitive function in patients with nasopharyngeal carcinoma.

Authors:  Weiyu Deng; Anqi Lin; Jialin Yang
Journal:  Oncol Lett       Date:  2020-08-20       Impact factor: 2.967

9.  Usefulness of Hybrid PET/MRI in Clinical Evaluation of Head and Neck Cancer Patients.

Authors:  Natalia Samolyk-Kogaczewska; Ewa Sierko; Dorota Dziemianczyk-Pakiela; Klaudia Beata Nowaszewska; Malgorzata Lukasik; Joanna Reszec
Journal:  Cancers (Basel)       Date:  2020-02-22       Impact factor: 6.639

10.  Preliminary clinical results for PET/MR compared with PET/CT in patients with nasopharyngeal carcinoma.

Authors:  Yong Cheng; Le Bai; Jingjie Shang; Yongjin Tang; Xueying Ling; Bin Guo; Jian Gong; Lu Wang; Hao Xu
Journal:  Oncol Rep       Date:  2019-10-30       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.